About Ophthalytics Inc (360 Intelligent Diagnostics)
Ophthalytics Inc. is an AI-driven healthcare company dedicated to preventing blindness by enabling early detection of vision-threatening diseases. Our platform, NSight360, combines assistive AI with human expertise to diagnose conditions like diabetic retinopathy, AMD, and glaucoma. By leveraging computer vision and deep learning, we empower primary care providers, home care, and assisted living facilities to conduct retinal screenings without the need for an in-house eye specialist. Founded in response to the global shortage of eye care professionals, our technology provides scalable, accurate, and cost-effective solutions to detect diseases early. With over 150,000 successful patient screenings, our impact spans hospitals, community clinics, and underserved regions, preventing blindness in at-risk populations. Unlike traditional ophthalmic solutions, NSight360 does not replace doctors but enhances their efficiency, ensuring better patient outcomes while meeting quality metrics and reimbursement requirements for healthcare providers. Our innovation aligns with health equity and accessibility goals, making vision care more inclusive and widespread. With deployments in the U.S. and internationally, and successful clinical studies and regulatory pathways, we are now expanding commercialization and seeking strategic partnerships to further scale our impact.